Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fuqiong Zhou"'
Publikováno v:
Medical Oncology. 40
Publikováno v:
Medical oncology (Northwood, London, England). 39(12)
Sorafenib (SOR) is currently the first line molecular targeting agent for advanced liver cancer therapy. Unfortunately, the insensitivity of liver cancer patients to SOR relatively limits its effectiveness. Huaier (HUA), a natural medicinal parasitic